Patients undergoing complex gastrointestinal malignancy surgeries experience various challenges such as immune system ...

Research on using sedation to improve patient tolerance to noninvasive ventilation (NIV) after traumatic chest injuries is ...

BioXcel Therapeutics (BTAI) stock gains as company shifts focus from commercial support for FDA-approved drug, Igalmi to lead ...

Objectives: Although generally effective for sedation during noninvasive procedures, dexmedetomidine as the sole agent has not been uniformly successful for invasive procedures. To overcome some ...

Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia ...

A study on the effects of commonly used anaesthetic and sedative drugs on cerebrospinal fluid flow and volume has uncovered findings regarding their impact on the brain's vital glymphatic system.

Using a rat model, the researchers found that ketamine–dexmedetomidine anaesthesia increased perivascular space size and consequently increased cerebrospinal fluid flow. This was uninfluenced by ...

The case reports described in this review article demonstrate the benefit that patients have derived from the adjunctive use of dexmedetomidine to their current treatment regimen for alcohol ...

X Biopharma (the "Company"), a specialty pharmaceutical company specializing in drug delivery systems and a leader in innovative healthspan nutraceuticals, has announced groundbreaking results from a ...

Reporting odds ratio (ROR), the proportional reporting ratio (PRR), and the Bayesian confidence propagation neural network (BCPNN) were employed to detect and assess adverse events associated with ...

The granted patent US11998529B2 outlines a method for treating agitation in human subjects using an oromucosal formulation of dexmedetomidine. The treatment protocol involves administering an initial ...